Ciprofloxacin Otic
Pricing Report NDC 42195-550-14

Current NADAC: $6.79379 per EA · Effective Jun 17, 2026 · Est. package price $95.11 (14 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The current wholesale acquisition cost for Ciprofloxacin Otic (NDC 42195-550-14) is $6.79379 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a provided by Xspire Pharma, Llc, this medication is distributed in a 14 CONTAINER in 1 CARTON / .25 mL in 1 CONTAINER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.79379
Per EA

Effective Date
Jun 17, 2026
Billable Units
14 EA
Estimated Package Price
$95.11
Data Status
As of Jul 01, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
14 CONTAINER in 1 CARTON / .25 mL in 1 CONTAINER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2013, the NADAC wholesale price for (NDC ) has moved within a range of $5.80186 to $7.38381 per EA. Over this 12 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.8019 - $7.3838
Market Volatility
27.27% Variance
Latest Trend
0.81%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jun 17, 2026 $6.79379 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 20, 2026 $6.84906 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 22, 2026 $6.80548 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 18, 2026 $6.93292 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 18, 2026 $6.97052 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 21, 2026 $7.03188 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 17, 2025 $7.00476 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 19, 2025 $7.23225 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 22, 2025 $7.38381 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 17, 2025 $7.27235 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 20, 2025 $6.84892 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 23, 2025 $6.84892 EAC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026